ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,210Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 559

$750K Total Retail Price of All Prescriptions

Rank: 11 out of 559

839 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 839 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 839 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,461 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 757 589 1 1
LEVOTHYROXINE SODIUM 700 564 2 2
OMEPRAZOLE 599 409 3 4
METFORMIN HCL 567 406 4 5
SIMVASTATIN 482 378 5 3
AMLODIPINE BESYLATE 459 322 6 6
HYDROCHLOROTHIAZIDE 428 344 7 8
HYDROCODONE-ACETAMINOPHEN 359 231 S3 8 7
FUROSEMIDE 295 232 9 11
LOSARTAN POTASSIUM 267 197 10 14
WARFARIN SODIUM 253 208 11 24
METOPROLOL TARTRATE 253 219 11 12
ATORVASTATIN CALCIUM 246 179 13 20
LOVASTATIN 230 193 14 10
METOPROLOL SUCCINATE 228 168 15 16
CRESTOR 228 182 15 33
ATENOLOL 224 153 17 15
GABAPENTIN 223 112 18 9
TRAMADOL HCL 207 120 19 27
OXYCODONE HCL 192 66 S2 20 32
PROAIR HFA 189 123 21 29
CITALOPRAM HBR 186 120 22 21
ZOLPIDEM TARTRATE 150 71 23 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 112 24 18
PANTOPRAZOLE SODIUM 144 134 25 41
PAROXETINE HCL 138 87 26 48
AZITHROMYCIN 137 98 27 39
DIOVAN 133 82 28 55
OXYCODONE-ACETAMINOPHEN 125 68 S2 29 44
GLIMEPIRIDE 124 77 30 53
SERTRALINE HCL 123 67 31 19
VERAPAMIL ER 114 112 32 89
CELEBREX 111 89 33 86
ALENDRONATE SODIUM 105 71 34 13
IBUPROFEN 103 62 35 30
POTASSIUM CHLORIDE 101 65 36 23
RANITIDINE HCL 99 78 37 26
NAPROXEN 97 54 38 79
FLUOXETINE HCL 96 66 39 37
GLIPIZIDE 95 90 40 31
ROPINIROLE HCL 95 65 40 95
TAMSULOSIN HCL 93 78 42 25
ALLOPURINOL 91 65 43 34
AMITRIPTYLINE HCL 89 61 R 44 58
CIPROFLOXACIN HCL 83 74 45 60
AMOX TR-POTASSIUM CLAVULANATE 83 59 45 98
LOSARTAN-HYDROCHLOROTHIAZIDE 82 70 47 52
OXYCODONE HCL-ACETAMINOPHEN 81 26 S2 48 70
DOXAZOSIN MESYLATE 79 77 49 43
SPIRONOLACTONE 79 55 49 74
NEXIUM 77 39 51 57
CARVEDILOL 75 60 52 38
TRIAMCINOLONE ACETONIDE 74 51 53 84
BENICAR HCT 73 63 54 221
CYCLOBENZAPRINE HCL 72 13 R 55 54
DICLOFENAC SODIUM 70 60 56 81
BENAZEPRIL HCL 67 59 57 85
CLOPIDOGREL 67 58 57 51
MELOXICAM 61 47 59 42
FENOFIBRATE 61 57 59 69
GLYBURIDE 60 54 R 61 45
CYMBALTA 58 0 62 78
ZETIA 58 42 62 101
PLAVIX 56 54 64 76
DILANTIN 56 24 64 206
CEPHALEXIN 55 42 66 80
TRAZODONE HCL 55 49 66 28
ESCITALOPRAM OXALATE 55 32 66 109
BYSTOLIC 54 54 69 161
PHENYTOIN SODIUM EXTENDED 54 21 69 123
GLIPIZIDE ER 54 51 69 77
PREDNISONE 54 45 69 49
ADVAIR DISKUS 54 36 69 46
DOXYCYCLINE HYCLATE 54 33 69 102
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 40 75 96
BENICAR 53 37 75 170
TRIAMTERENE-HCTZ 53 42 75 47
LANTUS 53 27 75 40
FLUTICASONE PROPIONATE 50 22 79 22
INSULIN SYRINGE 50 19 79 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.